表紙
市場調査レポート

世界の透析市場

Global Dialysis Market Outlook to 2020

発行 Koncept Analytics 商品コード 205940
出版日 ページ情報 英文 49 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
世界の透析市場 Global Dialysis Market Outlook to 2020
出版日: 2016年03月02日 ページ情報: 英文 49 Pages
概要

慢性腎臓病(CKD)は、その進行に沿って5段階に分類されますが、最も深刻な第5ステージは末期腎不全(ESRD)と呼ばれ、腎機能のわずか10%以下しか機能していない状態となっています。機能が戻ることはないため、この段階では治療は移植か透析の2つの選択肢のみとなります。慢性腎臓病は高血圧症、アテローム性動脈硬化症、遺伝的障害などが原因で発症します。

当レポートでは、全世界の透析市場の現状と将来展望について分析し、世界全体および各地域(特に中国)の市場構造・動向や、近年の市場の傾向、主な促進要因と課題、競争状況(市場シェアなど)、主要企業のプロファイルと事業戦略などを調査すると共に、今後の市場動向を推計して、その結果をお届けします。

第1章 概要

  • 慢性腎臓病 (CKD)
  • 末期腎不全(ESRD)
    • ESRDの治療法

第2章 市場分析

  • 世界の透析市場価格
  • 世界の透析製品市場
  • 世界の透析サービス市場
  • 世界の透析患者
  • 血液透析/腹膜透析患者

第3章 地域分析

  • 北米市場
  • アジア・太平洋地域市場
  • 欧州、中東アフリカ市場
  • ラテンアメリカ市場

第4章 市場のダイナミクス

  • 主な動向と発展
    • 技術の改良
    • 新製品開発
  • 成長促進要因
    • 世界の透析患者人口
    • 世界経済の成長
    • 医療費の増加
    • CKDおよびESRDの症例の増加
    • 老齢人口の増加
  • 課題
    • 透析のリスクと後遺症
    • 高額の治療費
    • 厳しい規制

第5章 競合情勢

  • 世界市場
  • 地域別市場
    • 北米
    • EMEA(欧州、中東、アフリカ)
    • アジア太平洋地域
    • ラテンアメリカ

第6章 企業プロファイル

  • DaVita Inc.
    • 事業内容
    • 主な財務指標
    • 事業戦略
  • Baxter International Inc.
    • 事業内容
    • 主な財務指標
    • 事業戦略
  • Fresenius Medical Care
    • 事業内容
    • 主な財務指標
    • 事業戦略

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Dialysis is the artificial process of eliminating waste and unwanted water from the blood. It is carried out by using a special fluid called dialysate, a mixture of pure water and chemicals, is carefully controlled to pull wastes out of your blood without removing substances your body needs. There are two types of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis removes wastes and water by circulating blood outside the body through an external filter, called a dialyzer and in peritoneal dialysis, wastes and water are removed from the blood inside the body using the peritoneum as a natural semipermeable membrane.

End stage renal disease (ESRD) is the last stage of chronic kidney disease. This is the situation when kidney is functioning below 10% of their normal function and they can no longer support a person's day to day life. The common causes of ESRD include high blood pressure, atherosclerosis, and genetic disorders. ESRD treatment is carried out either by dialysis or kidney transplant.

The report analyzes the global and regional dialysis markets. Some of the factors driving the growth of dialysis market include: growing number of diabetic patients, increasing dialysis population and incidences of chronic and infectious diseases which has further increased the healthcare expenditure and pharmaceutical sales. Market dynamics like key trends and development, challenges and growth drivers are discussed in detail. The key players having the vicious competition with each other are: DaVita, Baxter, and Fresenius. These players are being profiled in the report along with their key financials and strategies for growth.

Table of Contents

1. Overview

  • 1.1 Chronic Kidney Disease (CKD)
  • 1.2 End Stage Renal Disease (ESRD)
    • 1.2.1 Treatments for ESRD

2. Global Dialysis Market Analysis

  • 2.1 Global Dialysis Market Value
  • 2.2 Global Dialysis Products Market
  • 2.3 Global Dialysis Services Market
  • 2.4 Global Dialysis Patients
  • 2.5 Hemodialysis & Peritoneal Dialysis Patients

3. Regional Markets

  • 3.1 North America Dialysis Market
  • 3.2 Asia Pacific Dialysis Market
  • 3.3 EMEA Dialysis Market
  • 3.4 Latin America Dialysis Market

4. Market Dynamics

  • 4.1 Key Trends and Developments
    • 4.1.1 Improved Technologies
    • 4.1.2 New Product Development
  • 4.2 Growth Drivers
    • 4.2.1 Global Dialysis Patient Population
    • 4.2.2 Growing Global Economy
    • 4.2.3 Increasing Healthcare Expenditure
    • 4.2.4 Increasing Cases of CKD and ESRD
    • 4.2.5 Rising Ageing Population
  • 4.3 Challenges
    • 4.3.1 Associated Risks and After-effects of the Treatment
    • 4.3.2 High Treatment Costs
    • 4.3.3 Stringent Regulations

5. Competitive Landscape

  • 5.1 Global Market
  • 5.2 Regional Markets
    • 5.2.1 North America
    • 5.2.2 EMEA
    • 5.2.3 Asia-Pacific
    • 5.2.4 Latin America

6. Company Profiles

  • 6.1 DaVita Inc.
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Baxter International Inc.
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Fresenius Medical Care
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies

List of Charts

  • GFR across the Stages of CKD
  • Global Dialysis Market Value (2011-2015E)
  • Global Dialysis Market Value Forecast (2016-2020)
  • Global Dialysis Product Market (2011-2015E)
  • Global Dialysis Product Market Forecast (2016-2020)
  • Global Dialysis Services Market (2011-2015E)
  • Global Dialysis Services Market Forecast (2016-2020)
  • Global Dialysis Market-By Number of Patients (2012-2015E)
  • Global Dialysis Market Forecast- By Number of Patients (2016-2020)
  • Global Dialysis Market Share- by Segments (2014)
  • Global Hemodialysis & Peritoneal Patients (2012-2015E)
  • Global Hemodialysis & Peritoneal Patients Forecast (2012-2015E)
  • North America Dialysis Market Share-by Segments (2014)
  • North America Dialysis Patients (2012-2015E)
  • North America Dialysis Patients Forecast (2016-2020)
  • Asia Pacific Dialysis Market Share-by Segments (2014)
  • Asia Pacific Dialysis Patients (2012-2015E)
  • Asia Pacific Dialysis Patients Forecast (2016-2020)
  • EMEA Dialysis Market Share -by Segments (2014)
  • EMEA Dialysis Patients (2012-2015E)
  • EMEA Dialysis Patients Forecast (2016-2020)
  • Latin America Dialysis Market Share -by Segments (2014)
  • Latin America Dialysis Patients (2012-2015E)
  • Latin America Dialysis Patients Forecast (2016-2020)
  • Dialysis Patients Population Worldwide (2006-2015E)
  • Global GDP Growth (2011-2014)
  • Global Health Care Expenditure per Capita (2010-2014E)
  • Global Ageing Population (2006-2014)
  • Global Dialysis Market Share-By Patients (2014)
  • Global Dialysis Clinic Operator Share (2014)
  • Global Dialysis Products Market Share-By Company (2014)
  • Global Hemodialysis Dialysis Products Market Share-By Company (2014)
  • Global Peritoneal Dialysis Products Market Share-By Company (2014)
  • North America Dialysis Patients Treated by Company (2014)
  • North America Dialysis Clinic Operator Share (2014)
  • Top 10 Dialysis Service Providers in U.S-(2015)
  • EMEA Dialysis Patients Treated by Company (2014)
  • EMEA Dialysis Clinic Operator Share (2014)
  • Asia Pacific Dialysis Patients Treated by Company (2014)
  • Asia-Pacific Dialysis Clinic Operator Share (2014)
  • Latin America Dialysis Patients Treated by Company (2014)
  • Latin America Dialysis Clinic Operator Share (2014)
  • DaVita's Revenue Share by Business Segments (2014)
  • DaVita's Revenue Share in US (2014)
  • DaVita Inc. - Revenue and Net Income Analysis (2012-2014)
  • Baxter's Revenue by Business Segments (2014)
  • Baxter's Revenue by Geography (2014)
  • Baxter's Revenues and Net Income (2011-2014)
  • Fresenius Medical Care Revenue Share by Region (2014)
  • Fresenius Medical Care Revenue and Net Income (2012-2014)

List of Tables

  • Stages of CKD
  • Renoprotective Strategies for Slowing Progression of CKD
  • Symptoms & Treatment of Renal Failure
  • Advantages and Disadvantages of Dialysis Methods
  • Top 10 Dialysis Providers in U.S-Breakdown of Patients (2015)
Back to Top